Whether used to onboard employees, educate customers, or certify third-party partners, modern e-learning solutions provide ...

The proliferation of internet connectivity, the rise of SaaS applications, and growing demand for real-time access to ...

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong ...

Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to ...

Join us on September 13, 2025 for the free JHM HCM Patient Symposium. Meet the Johns Hopkins HCM team, learn about the latest in HCM treatments, and connect with other HCM patients. There is no cost ...

As of 1:24:17 PM GMT+1. Market Open. Loading Chart for HCM.L ...

The Special Access Programme (SAP) allows practitioners to request access to drugs that are unavailable for sale in Canada. This access is limited to patients with serious or life-threatening ...